Literature DB >> 11084221

Effects of repeated fluoxetine and citalopram administration on cytokine release in C57BL/6 mice.

M Kubera1, A Simbirtsev, R Mathison, M Maes.   

Abstract

This study examines the effects of repeated administration of the selective serotonin reuptake inhibitors (SSRIs), fluoxetine and citalopram (10 mg/kg, i.p.), on immunoreactivity in C57BL/6 mice. Immune functions were evaluated by the ability of splenocytes to reduce a tetrazolium salt to formazan (MTT test), to proliferate, and to produce cytokines, including interleukin (IL)-1, IL-2, IL-4, IL-6, IL-10 and interferon gamma (IFN gamma). Citalopram administered for 1, 2 and 4 weeks stimulates the proliferative activity of splenocytes and suppresses their ability to secrete the anti-inflammatory cytokine IL-4. Fluoxetine administration for 1 and 2 weeks, but not 4 weeks, stimulates the proliferative activity of splenocytes, whereas a 4-week administration of fluoxetine suppresses the secretion of IL-4. Four weeks of prolonged administration of citalopram and fluoxetine induces a significant increase in the production of IL-6 and IL-10, a cytokine with immunosuppressive and anti-inflammatory activities. The results show that, in C57BL/6 mice, the immunomodulatory effects of SSRIs depend on the SSRI used and the duration of administration.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11084221     DOI: 10.1016/s0165-1781(00)00184-0

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  15 in total

Review 1.  New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors.

Authors:  Michael Maes; Zdenĕk Fišar; Miguel Medina; Giovanni Scapagnini; Gabriel Nowak; Michael Berk
Journal:  Inflammopharmacology       Date:  2012-01-24       Impact factor: 4.473

Review 2.  Neuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategies.

Authors:  Jennifer M Loftis; Marilyn Huckans; Benjamin J Morasco
Journal:  Neurobiol Dis       Date:  2009-11-26       Impact factor: 5.996

3.  Can C-reactive protein inform antidepressant medication selection in depressed outpatients? Findings from the CO-MED trial.

Authors:  Manish K Jha; Abu Minhajuddin; Bharathi S Gadad; Tracy Greer; Bruce Grannemann; Abigail Soyombo; Taryn L Mayes; A John Rush; Madhukar H Trivedi
Journal:  Psychoneuroendocrinology       Date:  2017-01-24       Impact factor: 4.905

4.  Inflammatory and metabolic dysregulation and the 2-year course of depressive disorders in antidepressant users.

Authors:  Nicole Vogelzangs; Aartjan T F Beekman; Arianne K B van Reedt Dortland; Robert A Schoevers; Erik J Giltay; Peter de Jonge; Brenda W J H Penninx
Journal:  Neuropsychopharmacology       Date:  2014-01-20       Impact factor: 7.853

Review 5.  Eating ourselves to death (and despair): the contribution of adiposity and inflammation to depression.

Authors:  Richard C Shelton; Andrew H Miller
Journal:  Prog Neurobiol       Date:  2010-04-22       Impact factor: 11.685

6.  Pharmacogenomic predictors of citalopram treatment outcome in major depressive disorder.

Authors:  Firoza Mamdani; Marcelo T Berlim; Marie-Martine Beaulieu; Gustavo Turecki
Journal:  World J Biol Psychiatry       Date:  2013-03-26       Impact factor: 4.132

7.  Histologic and Biomechanical Evaluation of the Effects of Social Stress and the Antidepressant Fluoxetine on Tendon Healing in Rats.

Authors:  Muhammed Besir Ozturk; Onur Egemen; Salih Onur Basat; Ergün Bozdağ; Damlanur Sakız; Mithat Akan
Journal:  J Hand Microsurg       Date:  2015-10-15

8.  Immune-Regulatory and Molecular Effects of Antidepressants on the Inflamed Human Keratinocyte HaCaT Cell Line.

Authors:  Curzytek K; Maes M; Kubera M
Journal:  Neurotox Res       Date:  2021-05-04       Impact factor: 3.911

9.  Inflammation in depression: is adiposity a cause?

Authors:  Richard C Shelton; Andrew H Miller
Journal:  Dialogues Clin Neurosci       Date:  2011       Impact factor: 5.986

10.  The effects of antidepressant treatment on serum cytokines and nutritional status in hemodialysis patients.

Authors:  Sang-Kyu Lee; Hong-Seock Lee; Tae-Byeong Lee; Do-Hoon Kim; Ja-Ryong Koo; Yong-Ku Kim; Bong-Ki Son
Journal:  J Korean Med Sci       Date:  2004-06       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.